Skip to content

Eve & Co Included in Horizons Marijuana Life Sciences ETF

September 24, 2018

Eve & Co Included in Horizons Marijuana Life Sciences ETF

TORONTO, Sept. 24, 2018 –

Eve & Co Incorporated (the “Company” or “Eve”) (TSXV: EVE) is pleased to announce that it has been included in the Horizons Marijuana Life Sciences exchange-traded fund (TSX: HMMJ). To be eligible for inclusion in this ETF, issuers must meet certain minimum asset, market capitalization and liquidity thresholds.

“Eve is pleased to be included in the Horizons Marijuana Life Sciences ETF.  Eve has achieved successes and made strides in production, expansions, branding and, with the addition of sales and extracts authorizations, licensing and we hope that the inclusion in this ETF will enable us to reach additional shareholders who may share our direction,” said Melinda Rombouts, CEO of Eve.


Eve, through its wholly owned subsidiary Natural MedCo Ltd., is a licensed producer and seller of dried cannabis and cannabis plants, and producer of cannabis oil under the Access to Cannabis for Medical Purposes Regulations. Natural MedCo Ltd. is Canada’s first female founded licensed producer, and received its cultivation licence from Health Canada in 2016 and its sales licence from Health Canada in June 2018.

Eve is led by a team of agricultural experts and has a 220,000 sq. ft. scalable greenhouse production facility located in Middlesex County, Ontario with 32 acres of adjacent land for future expansion. Eve has broken ground on an additional 780,000 sq. ft. expansion, bringing Eve’s total anticipated greenhouse capacity to 1,000,000 sq. ft.

The TSX Venture Exchange (the “TSXV”) has neither approved nor disapproved the contents of this news release. Neither the TSXV nor its Regulation Service Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Certain statements in this press release constitute forward-looking information. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s future, strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict, including those described in the Company’s filing statement dated June 18, 2018 and available on the Company’s SEDAR profile. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities law.

For further information, please contact:

Melinda Rombouts
President and Chief Executive Officer
Eve & Co Incorporated
Telephone: (855) 628-6337
Shobana Thaya
Investor Relations
Telephone: (416) 807-1009